To treat HCC with low-expression of NR4A3, one approach we envision is to introduce NR4A3 protein or use gene therapy to deliver NR4A3 mRNA or DNA into HCC cells, thereby reinstating the expression of NR4A3 protein 44. The gene discussed is NR4A3; the disease is hepatocellular carcinoma.